BriaCell $BCTX adds Mayo Clinic to its pivotal Phase 3 trial in metastatic breast cancer, expanding to 59 sites across 15 states. Building on strong Phase 2 survival data, Bria-IMT™ continues gaining momentum. More:
https://globenewswire.com/news-release/2025/0...ancer.html